Specific involvement of caspases in the differentiation of monocytes into macrophages

Blood

Volumn 100, Issue 13, 2002, Pages 4446-4453

  Sordet, Olivier ^a,b,c   Rébé, Cédric ^a,b,c   Plenchette, Stéphanie ^a,b,c   Zermati, Yaël ^a,b,c   Hermine, Olivier ^a,b,c   Vainchenker, William ^a,b,c   Garrido, Carmen ^a,b,c   Solary, Eric ^a,b,c   Dubrez Daloz, Laurence ^a,b,c  

^a INSERM   (France)

^b CNRS   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; COLONY STIMULATING FACTOR 1; CYTOCHROME C; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHORBOL ESTER; PROTEIN; PROTEIN BCL 2; VIRUS PROTEIN;

ARTICLE; BACULOVIRUS; BLOOD CELL; CELL ASSAY; CELL DEATH; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME RELEASE; HUMAN; HUMAN CELL; MACROPHAGE; MITOCHONDRION; MONOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

EID: 0037114624     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-06-1778     Document Type: Article

References (48)

1. Nicholson DW. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 1999;6:1028-1042.
2. Solary E, Droin N, Sordet O, etal. Cell death pathways as targets for anticancer drugs. In: Baguley BC, Kerr DJ, eds. Anticancer Drug Development. San Diego, CA: Academic Press; 2002:55-76.
3. Scaffidi C, Fulda S, Srinivasan A, et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998;17:1675-1687.
4. Cerretti DP, Kozlosky CJ, Mosley B, et al. Molecular cloning of the interleukin-1 β converting enzyme. Science. 1992;256:97-100.
5. Ghayur T, Banerjee S, Hugunin M, et al. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature. 1997;386:619-623.
6. Wu DM, Zhang Y, Parada NA, et al. Processing and release of IL-16 from CD4+ but not CD8+ T cells is activation dependent. J Immunol. 1999;162:1287-1293.
7. Alam A, Cohen LY, Aouad S, Sekaly RP. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J Exp Med. 1999;190:1879-1890.
8. Kennedy NJ, Kataoka T, Tschopp J, Budd RC. Caspase activation is required for T cell proliferation. J Exp Med. 1999;190:1891-1896.
9. De Maria R, Zeuner A, Eramo A, et al. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature. 1999;401:489-493.
10. De Maria R, Testa U, Luchetti L, et al. Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood. 1999;93:796-803.
11. Zermati Y, Garrido C, Amsellem S, et al. Caspase activation is required for terminal erythroid differentiation. J Exp Med. 2001;193:247-254.
12. Ishizaki Y, Jacobson MD, Raff MC. A role for caspases in lens fiber differentiation. J Cell Biol. 1998;140:153-158.
13. Wride MA, Parker E, Sanders EJ. Members of the bcl-2 and caspase families regulate nuclear degeneration during chick lens fibre differentiation. Dev Biol. 1999;213:142-156.
14. Weil M, Raff MC, Braga VM. Caspase activation in the terminal differentiation of human epidermal keratinocytes. Curr Biol. 1999;9:361-364.
15. Palucka KA, Taquet N, Sanchez-Chapuis F, Gluckman JC. Dendritic cells as the terminal stage of monocyte differentiation. J Immunol. 1998;160:4587-4595.
16. Sordet O, Rebe C, Leroy I, et al. Mitochondria-targeting drugs arsenic trioxide and Ionidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis. Blood. 2001;97:3931-3940.
17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
18. Bruey JM, Ducasse C, Bonniaud P, et al. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol. 2000;2:645-652.
19. Dubrez L, Coll JL, Hurbin A, Solary E, Favrot MC. Caffeine sensitizes human H358 cell line to p53-mediated apoptosis by inducing mitochondrial translocation and conformational change of Bax protein. J Biol Chem. 2001;276:38980-38987.
20. Welgus HG, Connolly NL, Senior RM. 12-O-tetra-decanoyl-phorbol-13-acetate-differentiated U937 cells express a macrophage-like profile of neutral proteinases: High levels of secreted collagenase and collagenase inhibitor accompany low levels of intracellular elastase and cathepsin G. J Clin Invest. 1986;77:1675-1681.
21. Sordet O, Bettaieb A, Bruey JM, et al. Selective inhibition of apoptosis by TPA-induced differentiation of U937 leukemic cells. Cell Death Differ. 1999;6:351-361.
22. Sahara S, Aoto M, Eguchi Y, Imamoto N, Yoneda Y, Tsujimoto Y. Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation. Nature. 1999;401:168-173.
23. Loeffler M, Kroemer G. The mitochondrion in cell death control: Certainties and incognita. Exp Cell Res. 2000;256:19-26.
24. Takada Y, Hachiya M, Osawa Y, et al. 12-O-tetra- decanoylphorbol-13-acetate-induced apoptosis is mediated by tumor necrosis factor α in human monocytic U937 cells. J Biol Chem. 1999;274:28286-28292.
25. Bump NJ, Hackett M, Hugunin M, et al. Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science. 1995;269:1885-1888.
26. Garcia-Calvo M, Peterson EP, Leiting B, Ruel R, Nicholson DW, Thornberry NA. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem. 1998;273:32608-32613.
27. Craig RW. MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis. Leukemia. 2002;16:444-454.
28. Zamzami N, Brenner C, Marzo I, Susin SA, Kroemer G. Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene. 1998;16:2265-2282.
29. Mazel S, Burtrum D, Petrie HT. Regulation of cell division cycle progression by bcl-2 expression: A potential mechanism for inhibition of programmed cell death. J Exp Med. 1996;183:2219-2226.
30. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci U S A. 1993;90:3516-3520.
31. Fujise K, Zhang D, Liu J, Yeh ET. Regulation of apoptosis and cell cycle progression by MCL1: Differential role of proliferating cell nuclear antigen. J Biol Chem. 2000;275:39458-39465.
32. Zeuner A, Eramo A, Peschle C, De Maria R. Caspase activation without death. Cell Death Differ. 1999;6:1075-1080.
33. Ito Y, Pandey P, Sporn MB, Datta R, Kharbanda S, Kufe D. The novel triterpenoid CDDO induces apoptosis and differentiation of human osteosarcoma cells by a caspase-8 dependent mechanism. Mol Pharmacol. 2001;59:1094-1099.
34. Ranger AM, Malynn BA, Korsmeyer SJ. Mouse models of cell death. Nat Genet. 2001;28:113-118.
35. Wyllie AH, Golstein P. More than one way to go. Proc Natl Acad Sci U S A. 2001;98:11-13.
36. Pandey P, Nakazawa A, Ito Y, Datta R, Kharbanda S, Kufe D. Requirement for caspase activation in monocytic differentiation of myeloid leukemia cells. Oncogene. 2000;19:3941-3947.
37. Perlman H, Pagliari LJ, Georganas C, Mano T, Walsh K, Pope RM. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis. J Exp Med. 1999;190:1679-1688.
38. Gauthier R, Harnois C, Drolet JF, Reed JC, Vezina A, Vachon PH. Human intestinal epithelial cell survival: Differentiation state-specific control mechanisms. Am J Physiol Cell Physiol. 2001;280:C1540-C1554.
39. Fromm L, Overbeek PA. Inhibition of cell death by lens-specific overexpression of bcl-2 in transgenic mice. Dev Genet. 1997;20:276-287.
40. Hegde SP, Zhao J, Ashmun RA, Shapiro LH. c-Maf induces monocytic differentiation and apoptosis in bipotent myeloid progenitors. Blood. 1999;94:1578-1589.
41. Moulding DA, Giles RV, Spiller DG, White MR, Tidd DM, Edwards SW. Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cells. Blood. 2000;96:1756-1763.
42. Guedez L, Zucali J. Bleomycin-induced differentiation of bcl-2-transfected U937 leukemia cells. Cell Growth Differ. 1996;7:1625-1631.
43. Tenen DG, Hromas R, Licht JD, Zhang DE. Transcription factors, normal myeloid development, and leukemia. Blood: 1997;90:489-519.
44. Muller C, Leutz A. Chromatin remodeling in development and differentiation. Curr Opin Genet Dev. 2001;11:167-174.
45. Eymin B, Sordet O, Droin N, et al. Caspase-induced proteolysis of the cyclin-dependent kinase inhibitor p27Kip1 mediates its antiapoptotic activity. Oncogene. 1999;18:4839-4847.
46. Yang JY, Widmann C. Antiapoptotic signaling generated by caspase-induced cleavage of Ras-GAP. Mol Cell Biol. 2001;21:5346-5358.
47. Mundle SD, Venugopal P, Cartlidge JD, et al. Indication of an involvement of interleukin-1 β converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromes. Blood. 1996;88:2640-2647.
48. Boudard D, Sordet O, Vasselon C, et al. Expression and activity of caspases 1 and 3 in myelodysplastic syndromes. Leukemia. 2000;14:2045-2051.